Press Release
Article
Camber Launches Generic Quetiapine Tablets, USP
Key Takeaways
- Camber Pharmaceuticals expands its product line with Quetiapine Tablets, USP, enhancing treatment options for schizophrenia and bipolar disorders.
- Quetiapine is an atypical antipsychotic indicated for schizophrenia, manic, and depressive episodes in bipolar disorder.
Camber Pharmaceuticals is proud to expand its product line with Quetiapine Tablets, USP, offering patients a more affordable, high-quality treatment option.
Approximately 3.2 million Americans are affected by schizophrenia, while 5.7 million struggle with bipolar disorders. Camber Pharmaceuticals is proud to expand its product line with Quetiapine Tablets, USP, offering patients a high-quality treatment option. This addition supports our ongoing commitment to reducing drug shortages and improving access to essential medications.
Quetiapine Tablets, USP are an atypical antipsychotic indicated for the treatment of:
- Schizophrenia
- Bipolar I disorder, manic episodes
- Bipolar disorder, depressive episodes
Quetiapine Tablets, USP is available in:
- 25 mg | 100 count
- 50 mg | 100 count
- 100 mg | 100 count
- 200 mg | 100 count
- 300 mg | 60 & 100 count
- 400 mg | 100 & 500 count
To learn more about Quetiapine Tablets, please visit www.camberpharma.com/quetiapine
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
